Related Experiment Video
Updated: Jan 8, 2026

10:10
HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
8.7K
Single-cell RNA sequencing identifies ZBP1-dependent mechanisms in OSCC progression.
Xuyang Lin1,2,3, Chenlong Wang2, Chaoyang Li4
1Department of Oral Implantology, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Cell Death & Disease
|December 22, 2025
Summary
Z-DNA-binding protein 1 (ZBP1) drives oral squamous cell carcinoma (OSCC) by regulating cancer-associated fibroblasts (CAFs). ZBP1 deficiency inhibits OSCC growth by disrupting the ZBP1-CCL7/CCR1 signaling axis, offering a potential therapeutic target.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Oral squamous cell carcinoma (OSCC) is an aggressive malignancy with a poor prognosis, significantly influenced by its complex tumor microenvironment.
- Cancer-associated fibroblasts (CAFs) are key players in OSCC progression, mediating tumor development through secreted signaling molecules.
Purpose of the Study:
- To elucidate the molecular mechanism by which Z-DNA-binding protein 1 (ZBP1) promotes OSCC development via CAF regulation.
- To investigate the role of the ZBP1-CCL7/CCR1 signaling axis in mediating communication between CAFs and OSCC cells.
Main Methods:
- Establishment of orthotopic MOC1 transplantation and 4NQO-induced OSCC models in Zbp1 knockout mice.
- Single-cell RNA sequencing (scRNA-seq) for cellular heterogeneity and signaling analysis.
- In vitro CAF induction and Transwell co-culture systems, followed by in vivo rescue and antagonist experiments.
Main Results:
- ZBP1 deficiency in mice led to reduced OSCC growth, proliferation, and downregulation of proliferation-related pathways.
- scRNA-seq revealed significant attenuation of the CCL7-CCR1 signaling axis between CAFs and tumor cells in Zbp1-deficient models.
- ZBP1 was found to regulate CCL7 expression in CAFs, impacting CAF-mediated promotion of tumor cell proliferation, migration, and invasion.
Conclusions:
- ZBP1 is crucial for OSCC progression, acting as a bridge for CAF-tumor cell communication through the CCL7-CCR1 axis.
- Targeting the ZBP1-CCL7/CCR1 signaling pathway presents a potential therapeutic strategy for OSCC.

